Evidence map›Paper›PMID 31057103›Full record

ReviewCurrent medicinal chemistry2019

Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Kota Kurisu, Jong Youl Kim, Jesung You, Midori A Yenari

Open access · greenAbstract readReview
In one paragraph

Review in Current medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Research Progress of the Application of Hypothermia in the Eye.Oxidative medicine and cellular longevity · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kota KurisuDepartment of Neurology, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, United States.
Jong Youl KimDepartment of Neurology, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, United States.
Jesung YouDepartment of Neurology, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, United States.
Midori A YenariDepartment of Neurology, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, United States.
University of California, San Francisco · US

Funding

Inflammatory mechanisms in cerebral ischemiaR01NS106441 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YENARI, MIDORI A · 2019 to 2023
$1.7M
Calcium release-activated calcium (CRAC) channel inhibitors in experimental strokeR03NS101246 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YENARI, MIDORI A · 2017 to 2018
$153k
Heat shock proteins in brain ischemia and strokeI01BX000589 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI YENARI, MIDORI A · 2011 to 2019
–
BLRD VA I01 BX000589NINDS NIH HHS R01 NS106441NINDS NIH HHS R03 NS101246
6 · The paper itself

Abstract

Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs studying different models of neurological disease. Although this therapy has shown great promise, there are still challenges at the clinical level that limit the ability to apply this routinely to each pathological condition. In order to overcome issues involved in hypothermia therapy, understanding of this attractive therapy is needed. We review methodological concerns surrounding therapeutic hypothermia, introduce the current status of therapeutic cooling in various acute brain insults, and review the literature surrounding the many underlying molecular mechanisms of hypothermic neuroprotection. Because recent work has shown that body temperature can be safely lowered using pharmacological approaches, this method may be an especially attractive option for many clinical applications. Since hypothermia can affect multiple aspects of brain pathophysiology, therapeutic hypothermia could also be considered a neuroprotection model in basic research, which would be used to identify potential therapeutic targets. We discuss how research in this area carries the potential to improve outcome from various acute neurological disorders.

Indexed as

Hypothermia, InducedNeuroprotectionAcute DiseaseAnimalsBrainHumansNervous System Diseasescardiac arrestHypothermiahypoxic- ischemic encephalopathypharmacology induced hypothermiastroketraumatic brain injury.

Identifiers

PMID31057103
PMCPMC6913523
OpenAlexW2944543816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.